HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Experimental Liver Cirrhosis

Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
Also Known As:
Liver Cirrhosis, Experimental; Cirrhoses, Experimental Liver; Cirrhosis, Experimental Liver; Experimental Liver Cirrhoses; Liver Cirrhoses, Experimental; Experimental Hepatic Cirrhosis; Hepatic Cirrhosis, Experimental
Networked: 119 relevant articles (1 outcomes, 17 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Liver Cirrhosis (Hepatic Cirrhosis)
2. Fibrosis (Cirrhosis)
3. Neoplasms (Cancer)
4. Poisoning
5. Liver Diseases (Liver Disease)

Experts

1. Armendariz-Borunda, Juan: 2 articles (11/2006 - 10/2006)
2. Al-Attar, Atef M: 1 article (03/2015)
3. Shawush, Nessreen A: 1 article (03/2015)
4. Sansoè, Giovanni: 1 article (07/2013)
5. Parola, Maurizio: 1 article (07/2013)
6. Mastrocola, Raffaella: 1 article (07/2013)
7. Paternostro, Claudia: 1 article (07/2013)
8. Aragno, Manuela: 1 article (07/2013)
9. D'Albuquerque, Luiz Augusto Carneiro: 1 article (08/2012)
10. Galvão, Flavio Henrique Ferreira: 1 article (08/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Experimental Liver Cirrhosis:
1. FP 736-04IBA
2. Thioacetamide (Thioacetamid)IBA
3. Messenger RNA (mRNA)IBA
4. Carbon Tetrachloride (Tetrachloromethane)IBA
5. SodiumIBA
6. RNA (Ribonucleic Acid)IBA
7. Blood Proteins (Serum Proteins)IBA
8. Tissue Inhibitor of Metalloproteinase-1IBA
9. ZincIBA
10. Triamcinolone (Aristocort)FDA Link

Therapies and Procedures

1. Hepatectomy
2. Ligation
3. Oral Administration
4. Microspheres (Microsphere)
5. Fetal Tissue Transplantation